Estudios originales

Published on 26 de septiembre de 2015 | http://doi.org/10.5867/medwave.2015.08.6265

Duloxetine for the treatment of painful diabetic peripheral neuropathy in Venezuela: economic evaluation

Back to article Table 1.

Resource use and expect cost associated to adverse events and lack of efficacy.